IP Library Granted Patent US 8,338,602
Granted Patent B2
US 8,338,602 · App. 12/781,899 · Granted Dec 25, 2012

Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids

Assignee: University of Maryland, Baltimore County
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,338,602
App. No.
12/781,899
Granted
Dec 25, 2012
Kind
B2
Abstract

Quaternary nitrogen heterocyclic boronic acid-containing compounds are described, which are sensitive to glucose and fructose, as well as a variety of other physiologically important analytes, such as aqueous chloride and iodide, and a method of using the compounds. Also disclosed is a contact lens doped with the quaternary nitrogen heterocyclic boronic acid-containing compound, and a method of using the doped contact lens to measure the concentration of analyte in tears under physiological conditions.

Claims (8)

1. A fluorescence compound having the following structure:

wherein X is chloride, bromide or iodide and R is selected from the group consisting of H, straight chain or branched C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, aryl group, hydroxyl, cyano, and NR 1 R 2 , wherein R 1 and R 2 may be the same as or different from one another and is independently selected from the group consisting of H and C 1 -C 4 alkyl groups.

2. The compound of claim 1 , wherein the fluorescence intensity of the compound changes in the presence of glucose and wherein the fluorescence intensity of the compound decreases in the presence of glucose.

3. An assay kit for measuring the concentration of glucose in a physiological fluid comprising a container containing a fluorescence compound having the structure:

wherein X is chloride, bromide or iodide and R is selected from the group consisting of H, straight chain or branched C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, aryl group, hydroxyl, cyano, and NR 1 R 2 , wherein R 1 and R 2 may be the same as or different from one another and is independently selected from the group consisting of H and C 1 -C 4 alkyl groups.

4. The kit of claim 3 , wherein the physiological fluid is blood.

5. A fluorescence compound having the following structure

wherein X is chloride, bromide or iodide and R is selected from the group consisting of H, straight chain or branched C 1 -C 4 alkyl group, C 1 -C 4 alkoxy group, aryl group, hydroxyl, cyano, and NR 1 R 2 , wherein R 1 and R 2 may be the same as or different from one another and is independently selected from the group consisting of H and C 1 -C 4 alkyl groups, wherein the B(OH) 2 functional group is in the meta or para position.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2013
From: UNIVERSITY OF MARYLAND, BALTIMORE COUNTY
To: GEDDES, CHRIS, DR.
Reel/Frame 030586/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2013
From: LAKOWICZ, JOSEPH
To: UNIVERSITY OF MARYLAND, BALTIMORE
Reel/Frame 029729/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE
To: UNIVERSITY OF MARYLAND BALTIMORE COUNTY
Reel/Frame 024899/0263 →
Continuity (5)
Division 11318663 · Dec 27, 2005
Continuation In Part PCTUS2004022717 · Jun 28, 2004
Provisional Application 60483202 · Jun 27, 2003
Provisional Application 60483124 · Jun 27, 2003
Related Publication 20100297016A1 · Nov 25, 2010